The determination of glial fibrillary acidic protein for the diagnosis and histogenetic study of central nervous system tumors: a study of 152 cases.
Glial fibrillary acidic protein (GFAP) was purified from human spinal cord and cerebral white matter. GFAP was localized by an immuno-peroxidase method in normal adult and fetal human brains, rat brains, and 152 central nervous system (CNS) tumors. GFAP was found in reactive and normal astrocytes, immature cells of fetal brain at the 18th to 21st gestational weeks, and normal rat astrocytes. This GFAP staining was quite specific for glial tumors, including astrocytomas, glioblastomas, astroblastomas, and ependymomas. GFAP-positive cells were also found in oligodendrogliomas and choroid plexus papillomas, and they were interpreted as being astroglial or ependymal differentiations. Stromal cells in cerebellar hemangioblastomas were negative. However, engulfed astrocytes were found at the periphery of such tumors and often adjacent to the proliferate blood vessels. In meningiomas, neurinomas, metastatic carcinomas, pituitary adenomas and other non-glial tumors, GFAP-positive cells were not identified.
D000818:Animals; D001254:Astrocytoma / Q000175:diagnosis; D001923:Brain Chemistry; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000473:pathology; D019411:Clinical Laboratory Techniques; D004806:Ependymoma / Q000175:diagnosis; D005260:Female; D005333:Fetus; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis*; D005910:Glioma / Q000175:diagnosis; D006801:Humans; D011247:Pregnancy; D051381:Rats; D012016:Reference Values; D013116:Spinal Cord / Q000032:analysis
D005904:Glial Fibrillary Acidic Protein